Cargando…
Anti-diabetic Effects of Clostridium butyricum CGMCC0313.1 through Promoting the Growth of Gut Butyrate-producing Bacteria in Type 2 Diabetic Mice
Patients with type 2 diabetes (T2D) have decreased butyrate-producing bacteria. We hypothesized that supplementation with butyrate-producing bacteria may exert beneficial effects on T2D. The current study investigated the effects of well-characterized butyrate-producing bacteria Clostridium butyricu...
Autores principales: | Jia, Lingling, Li, Dongyao, Feng, Ninghan, Shamoon, Muhammad, Sun, Zhenghua, Ding, Lei, Zhang, Hao, Chen, Wei, Sun, Jia, Chen, Yong Q |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5539151/ https://www.ncbi.nlm.nih.gov/pubmed/28765642 http://dx.doi.org/10.1038/s41598-017-07335-0 |
Ejemplares similares
-
Clostridium butyricum CGMCC0313.1 Protects against Autoimmune Diabetes by Modulating Intestinal Immune Homeostasis and Inducing Pancreatic Regulatory T Cells
por: Jia, Lingling, et al.
Publicado: (2017) -
Clostridium Butyricum CGMCC0313.1 Modulates Lipid Profile, Insulin Resistance and Colon Homeostasis in Obese Mice
por: Shang, Haixiao, et al.
Publicado: (2016) -
Aerosol Inhalation of Heat-Killed Clostridium butyricum CGMCC0313-1 Alleviates Allergic Airway Inflammation in Mice
por: Li, Laodong, et al.
Publicado: (2022) -
Oral administration of Clostridium butyricum CGMCC0313-1 inhibits β-lactoglobulin-induced intestinal anaphylaxis in a mouse model of food allergy
por: Zhang, Juan, et al.
Publicado: (2017) -
Clostridium butyricum Reduces Obesity in a Butyrate-Independent Way
por: Liao, Jingyi, et al.
Publicado: (2023)